which climbed 3.86 percent to P202.00 and SM Prime Holdings Inc. Gainers led losers, 96 to 81, while 43 issues were unchanged.įive of the 10 most active stocks ended in the green, led by International Container Terminal Services Inc. The broader all-shares index went up 23 points, or 0.67 percent, to settle at 3,467.11, on a value turnover of P53 billion.
The 30-company Philippine Stock Exchange index gained 46 points, or 0.73 percent, to close at 6,508.34, as four of the six subsectors advanced, with services leading the way. Stocks rose for a second day on hopes China will unveil fresh measures to kickstart its ailing economy, while the dollar struggled to bounce from losses fueled by bets the Federal Reserve is near the end of its tightening cycle. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines. On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. Read More: Penny Stocks - How to Profit Without Getting Scammed If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that ’s writers disclose this fact and warn readers of the risks. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. NIO Stock: Nio Just Signed a New 5-Year Agreement.10 Things for Investors to Know About the First Citizens-Silicon Valley Bank Deal.You can find out more on these matters at the links below! More Monday Stock Market News We’ve got all of the hottest stock market news worth knowing about on Monday! A few examples include what has shares of First Citizens Bancshares (NASDAQ: FCNCA) and Nio (NYSE: NIO) stock moving today. Investors seeking more of the latest stock market news will want to stick around! UBX stock is down 51.8% as of Monday morning. To put that in perspective, the company’s daily average trading volume is about 255,000 shares. Alongside that comes heavy trading of UBX stock with some 4 million units on the move.
#UBX STOCK NEWS TRIAL#
Investors aren’t reacting well to today’s clinical trial results and that has UBX shares taking a beating. We look forward to sharing 48-week data in our BEHOLD DME study in the coming weeks.” What This Means for UBX Stock “Whereas today’s results from the ENVISION study and our Phase 2 BEHOLD study both show encouraging signs of biological activity of UBX1325, the relatively stronger efficacy we observed in DME may be related to the distinct underlying pathophysiologies of the two diseases. Unity Biotechnology Chief Medical Officer Jamie Dananberg said the following about the news: Despite this, though, the company isn’t giving up on UBX1325 just yet. It failed to meet the non-inferiority threshold when compared to aflibercept after 24 weeks. The bad news for investors in UBX stock is that the study didn’t go well. Specifically, the study targeted those not seeing benefits from their anti-VEGF therapy. UBX1325 is a treatment in development that Unity is testing for use with patients suffering from wet age-related macular degeneration ( AMD). Unity Biotechnology (NASDAQ: UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325.
0 kommentar(er)
